365 related articles for article (PubMed ID: 27237757)
21. Meningoencephalitis as an initial manifestation of neuromyelitis optica spectrum disorder.
Wang JY; Wang K; Chen XW; Wang JW; Zhang K; Xu MW; Luo BY
Mult Scler; 2013 Apr; 19(5):639-43. PubMed ID: 23069875
[TBL] [Abstract][Full Text] [Related]
22. Severe Relapse After Cessation of Immunosuppressive Therapy in a Patient With Neuromyelitis Optica Spectrum Disorder.
Hyun JW; Kim G; Kim Y; Jeong IH; Kim SH; Kim HJ
Neurologist; 2016 Nov; 21(6):97-98. PubMed ID: 27801768
[TBL] [Abstract][Full Text] [Related]
23. Neuromyelitis optica spectrum disorder in a tertiary hospital in the Philippines: a case series.
Espiritu AI; Mesina BVQ; Puerto AAD; Reyes NGD; Damian LF; Pascual V JLR
Mult Scler Relat Disord; 2019 Jun; 31():124-130. PubMed ID: 30981191
[TBL] [Abstract][Full Text] [Related]
24. [Seroconversion of anti-aquaporin-4 antibody in a patient with neuromyelitis optica spectrum disorder: a case report].
Shimoyama K; Akahori M; Ishio Y; Yanagihara C
Rinsho Shinkeigaku; 2022 May; 62(5):351-356. PubMed ID: 35474282
[TBL] [Abstract][Full Text] [Related]
25. Therapeutic efficacy of interferon β-1b in Japanese patients with optic-spinal multiple sclerosis.
Shimizu Y; Fujihara K; Kubo S; Takahashi T; Misu T; Nakashima I; Yokoyama K; Itoyama Y; Uchiyama S
Tohoku J Exp Med; 2011 Mar; 223(3):211-4. PubMed ID: 21403431
[TBL] [Abstract][Full Text] [Related]
26. Neuromyelitis optica spectrum disorder and multiple sclerosis: Differentiation by a multimodal approach.
Ota M; Sato N; Okamoto T; Noda T; Araki M; Yamamura T; Kunugi H
Mult Scler Relat Disord; 2015 Nov; 4(6):515-20. PubMed ID: 26590657
[TBL] [Abstract][Full Text] [Related]
27. Spectrum of pediatric neuromyelitis optica.
Lotze TE; Northrop JL; Hutton GJ; Ross B; Schiffman JS; Hunter JV
Pediatrics; 2008 Nov; 122(5):e1039-47. PubMed ID: 18838462
[TBL] [Abstract][Full Text] [Related]
28. IFNβ-1b may severely exacerbate Japanese optic-spinal MS in neuromyelitis optica spectrum.
Shimizu J; Hatanaka Y; Hasegawa M; Iwata A; Sugimoto I; Date H; Goto J; Shimizu T; Takatsu M; Sakurai Y; Nakase H; Uesaka Y; Hashida H; Hashimoto K; Komiya T; Tsuji S
Neurology; 2010 Oct; 75(16):1423-7. PubMed ID: 20826711
[TBL] [Abstract][Full Text] [Related]
29. Eculizumab in Aquaporin-4-Positive Neuromyelitis Optica Spectrum Disorder.
Pittock SJ; Berthele A; Fujihara K; Kim HJ; Levy M; Palace J; Nakashima I; Terzi M; Totolyan N; Viswanathan S; Wang KC; Pace A; Fujita KP; Armstrong R; Wingerchuk DM
N Engl J Med; 2019 Aug; 381(7):614-625. PubMed ID: 31050279
[TBL] [Abstract][Full Text] [Related]
30. [Neuromyelitis optica].
Kvistad SA; Wergeland S; Torkildsen Ø; Myhr KM; Vedeler CA
Tidsskr Nor Laegeforen; 2013 Oct; 133(19):2057-61. PubMed ID: 24129537
[TBL] [Abstract][Full Text] [Related]
31. Neuromyelitis optica spectrum disorder (NMOSD) presenting as acute transverse myelitis with positive aquaporin 4 antibodies.
Thornley K; Canepa C
BMJ Case Rep; 2021 Jan; 14(1):. PubMed ID: 33504530
[TBL] [Abstract][Full Text] [Related]
32. Extensive white matter lesions after 2 years of fingolimod: Progressive multifocal leukoencephalopathy or MS relapse?
Boudot de la Motte M; Louapre C; Bertrand A; Reach P; Lubetzki C; Papeix C; Maillart E
Mult Scler; 2017 Apr; 23(4):614-616. PubMed ID: 28273764
[TBL] [Abstract][Full Text] [Related]
33. [A Case of Neuromyelitis Optica Spectrum Disorder Who Relapsed Under Oral Corticosteroid Treatment with Multiple Cerebrospinal Lesions and Severe Neurological Deficits].
Uemoto Y; Shiraishi W; Fujiki R; Furuta K
J UOEH; 2021; 43(2):255-261. PubMed ID: 34092770
[TBL] [Abstract][Full Text] [Related]
34. Hepatitis C virus (HCV) reactivation during fingolimod treatment for relapsing and remitting multiple sclerosis.
Tagawa A; Ogawa T; Tetsuka S; Otsuka M; Hashimoto R; Kato H; Ando K; Tanabe H
Mult Scler Relat Disord; 2016 Sep; 9():155-7. PubMed ID: 27645365
[TBL] [Abstract][Full Text] [Related]
35. Linear lesions may assist early diagnosis of neuromyelitis optica and longitudinally extensive transverse myelitis, two subtypes of NMOSD.
Cai W; Tan S; Zhang L; Shan Y; Wang Y; Lin Y; Zhou F; Zhang B; Chen X; Zhou L; Wang Y; Huang X; Men X; Li H; Qiu W; Hu X; Lu Z
J Neurol Sci; 2016 Jan; 360():88-93. PubMed ID: 26723980
[TBL] [Abstract][Full Text] [Related]
36. Spectrum of MRI brain lesion patterns in neuromyelitis optica spectrum disorder: a pictorial review.
Wang KY; Chetta J; Bains P; Balzer A; Lincoln J; Uribe T; Lincoln CM
Br J Radiol; 2018 Jun; 91(1086):20170690. PubMed ID: 29388807
[TBL] [Abstract][Full Text] [Related]
37. [A case of recurrent optic neuritis associated with cerebral and spinal cord lesions and autoantibodies against myelin oligodendrocyte glycoprotein relapsed after fingolimod therapy].
Miyazaki T; Nakajima H; Motomura M; Tanaka K; Maeda Y; Shiraishi H; Tsujino A
Rinsho Shinkeigaku; 2016 Apr; 56(4):265-9. PubMed ID: 27010093
[TBL] [Abstract][Full Text] [Related]
38. Prognostic factors and disease course in aquaporin-4 antibody-positive patients with neuromyelitis optica spectrum disorder from the United Kingdom and Japan.
Kitley J; Leite MI; Nakashima I; Waters P; McNeillis B; Brown R; Takai Y; Takahashi T; Misu T; Elsone L; Woodhall M; George J; Boggild M; Vincent A; Jacob A; Fujihara K; Palace J
Brain; 2012 Jun; 135(Pt 6):1834-49. PubMed ID: 22577216
[TBL] [Abstract][Full Text] [Related]
39. Neuromyelitis optica: an overview.
Nandhagopal R; Al-Asmi A; Gujjar AR
Postgrad Med J; 2010 Mar; 86(1013):153-9. PubMed ID: 20237009
[TBL] [Abstract][Full Text] [Related]
40. An Autopsy Confirmed Neuromyelitis Optica Spectrum Disorder with Extensive Brain White Matter Lesion and Optic Neuritis but Intact Spinal Cord, Clinically Mimicking a Secondary Progressive Multiple Sclerosis-like Course.
Azuma F; Nokura K; Kako T; Yoshida M; Tatsumi S
Intern Med; 2022 May; 61(9):1415-1422. PubMed ID: 34645756
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
